Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEV-45478 in NASH with T2DM
NCT02769091Phase 2Withdrawn
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Sep 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of TEV-45478 in Nonalcoholic steatohepatitis (NASH), sponsored by Teva Pharmaceutical Industries Ltd.. Planned start Sep 2016; status: withdrawn.
02
Drugs
TEV-45478
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02769091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769091.